Blood sampling for microRNA testing for migraine disorders

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 9 Dec 2020: Trial registered, NCT04659226

The trials

NCT04659226: MicroRNA Profile and Erenumab Treatment

State
Completed
Phase
No phase
People
40 taking part
Started
1 Jul 2021
Primary completion
31 Dec 2022
Arms
Episodic or chronic migraine
Results
None posted
  1. 9 Dec 2020: Trial registered
  2. 1 Jul 2021: Trial started
  3. 30 Apr 2023: Trial completed

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Gene therapy.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.